Close

Division of Gastroenterology, Hepatology and Nutrition Pegylated Interferon +/- Ribavirin For Children With Hcv

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

Principal Investigator: Maureen Jonas, MD

Department: Gastroenterology, Center for Childhood Liver Disease

Protocol Status: Recruitment Complete

Trial Description: This study tested the treatment of hepatitis C in children with pegylated interferon with or without ribavirin. This research also included examination of the effects of hepatitis C and its treatment on weight and growth, as well as quality of life and behavior and cognitive function in these children.  Although the study is complete, data analysis and publications are ongoing.

PI phone: Center for Childhood Liver Disease 617-355-5837

Request an Appointment

If this is a medical emergency, please dial 9-1-1. This form should not be used in an emergency.

Patient Information
Date of Birth:
Contact Information
Appointment Details
Send RequestIf you do not see the specialty you are looking for, please call us at: 617-355-6000.International visitors should call International Health Services at +1-617-355-5209.
Please complete all required fields

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

Thank you.

Your request has been successfully submitted

You will be contacted within 1 business day.

If you have questions or would like more information, please call:

617-355-6000 +1-617-355-6000
close
Find a Doctor
Search by Clinician's Last Name or Specialty:
Select by Location:
Search by First Letter of Clinician's Last Name: *ABCDEFGHIJKLMNOPQRSTUVWXYZ
BrowseSearch
Condition & Treatments
Search for a Condition or Treatment:
Show Items Starting With: *ABCDEFGHIJKLMNOPQRSTUVWXYZ
View allSearch
Locations

Contact the Division of Gastroenterology, Hepatology and Nutrition

The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO
Close